Effects of pyridostigmine bromide vs. fludrocortison in the treatment of orthostatic hypotension in Parkinson’s disease
Objective: To report results of an investigator-initiated trial to show the non-inferiority of pyridostigmine bromide (PB) vs. fludrocortisone (FC) in the treatment of symptomatic orthostatic…Use of nicotine gum to treat acute low blood pressure in Parkinson’s disease
Objective: To evaluate (1) how nicotine chewing gum is tolerated (2) how nicotine chewing gum affects acute low blood pressure (BP) in Parkinson's disease (PD).…Prevalence of orthostatic hypotension after a low subacute levodopa dose in patients with parkinsonism
Objective: To evaluate the prevalence of orthostatic hypotension (OH) after a low subacute levodopa (LD) dose in patients with diagnosis of Parkinson's disease (PD) or…Cognitive and behavioral side effects in patients treated with droxidopa for neurogenic orthostatic hypotension
Objective: To describe adverse behavioral symptoms attributed to droxidopa therapy for neurogenic orthostatic hypotension (nOH). Background: Droxidopa, a norepinephrine (NE) precursor, improves symptoms of neurogenic…Prevalence and risk factors for orthostatic hypotension in early PD
Objective: To identify the prevalence of orthostatic hypotension (OH) in early Parkinson's disease (PD) and identify clinical features associated with greater postural drop in BP…Prevalence and risk factors of orthostatic hypotension in Thai Parkinson’s disease patients
Objective: To determine the prevalence of OH and identify risk factors associated with OH in Thai PD patients. Background: Orthostatic hypotension (OH) represents one of…RBD increase non-motor symptom in Parkinson’s disease
Objective: To investigate the relationship between the RBD and other non-motor symptoms in Parkinson's disase. Background: Rapid eye movement sleep behavior disorder (RBD) is frequent…Orthostatic intolerance and falls in Parkinson’s disease
Objective: Primary objective: to assess the relationship between falls, orthostatic intolerance and orthostatic hypotension (OH) in patients with Parkinson's disease (PD). Secondary objective: to assess…Cerebral vasoreactivity in Parkinson’s disease and multiple system atrophy: A pilot study
Objective: To compare cerebral vasoreactivity in Parkinson´s disease (PD) and multiple system atrophy (MSA) patients with or without cardiovascular autonomic failure (CAF). Background: CAF is…The relationship between blood pressure, sex and survival in multiple system atrophy
Objective: To investigate the effect of BP parameters on survival in MSA patients by MSA type and sex. Background: Multiple system atrophy (MSA) is a…
- « Previous Page
- 1
- …
- 5
- 6
- 7